Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
At equivalent Thrombotest basal values on undiluted non-contacted plasma, there is no difference between coumarin plasma and liver damage plasma in the dilution curve system. A hemophilia BM plasma with longer basal clotting times yielded a much flatter curve and a very large "inhibitory" effect (greater than 6 Units). A coumarin plasma with the same basal Thrombotest clotting times as Hemophilia BM plasma, namely 100 seconds, yielded a much steeper curve and a very low inhibition (0.7 Units). These findings are against the presence of inhibitors in coumarin or liver damage plasmas.
D001778:Blood Coagulation Disorders / Q000175:diagnosis*; D001780:Blood Coagulation Tests; D003374:Coumarins / Q000627:therapeutic use; D002836:Hemophilia B / Q000097:blood; D006801:Humans; D008107:Liver Diseases / Q000150:complications*
D003374:Coumarins